 |
|
|
| |
Analysis of Efficacy by Baseline Viral Load: Phase 3 Study Comparing Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF (Quad) versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF in Treatment Naïve HIV-1 Infected Subjects: Week 48 Results
|
| |
| |
Reported by jules Levin
19th Intl AIDS Conference July 22-27 2012 Wash DC USA
E DeJesus1, JK Rockstroh2, K Henry3, J-M Molina4, J Gathe5,
S Ramanathan6, X Wei6, J Szwarcberg6, M Rhee6, A Cheng6
1Orlando Immunology Center, Orlando, FL, US; 2Department of Medicine I, University of Bonn, Bonn, Germany; 3Hennepin County Medical Center, Minneapolis, MN, US; 4Saint Louis Hospital, Paris, France; 5Therapeutic Concepts P.A., Houston, TX, US; 6Gilead Sciences, Foster City, CA, US
|
| |
|
|
|
|
|
